Showing results (1-10 of 246) with videos related to
Sort By:
Pageof 25
Nature Reviews. Cardiology|June 23, 2010
Novel therapeutic targets for hypertensionLudovit Paulis, Thomas UngerEuropean Heart Journal|September 29, 2011
Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approachesThomas Unger, Ludovit Paulis, Domenic A SicaNature Reviews. Cardiology|March 21, 2012
Key advances in antihypertensive treatmentLudovit Paulis, Ulrike M Steckelings, Thomas UngerExpert Opinion on Emerging Drugs|September 13, 2011
Emerging drugs which target the renin-angiotensin-aldosterone systemUlrike Muscha Steckelings, Ludovit Paulis, Thomas Unger, et al.Current Opinion in Nephrology and Hypertension|January 20, 2012
AT2 receptor agonists: hypertension and beyondUlrike M Steckelings, Ludovit Paulis, Pawel Namsolleck, et al.Journal of Hypertension|September 9, 2010
The angiotensin AT2 receptor in left ventricular hypertrophyU Muscha Steckelings, Robert E Widdop, Ludovit Paulis, et al.Integrated Blood Pressure Control|January 1, 2014
Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressureLeon A Danyel, Patrick Schmerler, Ludovit Paulis, et al.Drugs|December 4, 2015
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic DisordersLudovit Paulis, Sébastien Foulquier, Pawel Namsolleck, et al.Journal of Pineal Research|April 19, 2007
Melatonin as a potential antihypertensive treatmentFedor Simko, Ludovit PaulisCurrent Pharmaceutical Design|September 10, 2015
N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brainJaroslav Hrenak, Ludovit Paulis, Fedor SimkoPageof 25